Integrated high-throughput analysis identifies super enhancers associated with chemoresistance in SCLC

被引：0
|
作者：
Jiarong Bao
Man Li
Shumei Liang
Yunchu Yang
Jingfang Wu
Qingqing Zou
Shun Fang
Size Chen
Linlang Guo
机构：
[1] Zhujiang Hospital,Department of Pathology
[2] Southern Medical University,Department of Pathology
[3] The Fifth Affiliated Hospital,Department of Oncology
[4] Southern Medical University,undefined
[5] The First Affiliated Hospital of Guangdong Pharmaceutical University,undefined
来源：
BMC Medical Genomics | / 12卷
关键词：
Small cell lung cancer; Chemoresistance; Super enhancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 10 条
  • [1] Integrated high-throughput analysis identifies super enhancers associated with chemoresistance in SCLC
    Bao, Jiarong
    Li, Man
    Liang, Shumei
    Yang, Yunchu
    Wu, Jingfang
    Zou, Qingqing
    Fang, Shun
    Chen, Size
    Guo, Linlang
    BMC MEDICAL GENOMICS, 2019, 12 (1)
  • [2] Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer
    Zeng, Jie
    Chen, Jiahong
    Li, Maozhang
    Zhong, Chuanfan
    Liu, Zezhen
    Wang, Yan
    Li, Yuejiao
    Jiang, Funeng
    Fang, Shumin
    Zhong, Weide
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [3] High-Throughput Transcriptomics Identifies Chemoresistance-Associated Gene Expression Signatures in Human Angiosarcoma
    Khor, Glenys Mai Shia
    Haghani, Sara
    Tan, Tiffany Rui En
    Lee, Elizabeth Chun Yong
    Kannan, Bavani
    Lim, Boon Yee
    Lee, Jing Yi
    Guo, Zexi
    Ko, Tun Kiat
    Chan, Jason Yongsheng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (19)
  • [4] Integrated analysis of scRNA-seq and bulk RNA-seq identifies FBXO2 as a candidate biomarker associated with chemoresistance in HGSOC
    Lai, Wenwen
    Xie, Ruixiang
    Chen, Chen
    Lou, Weiming
    Yang, Haiyan
    Deng, Libin
    Lu, Quqin
    Tang, Xiaoli
    HELIYON, 2024, 10 (07)
  • [5] Bioinformatics analysis identifies potential chemoresistance-associated genes across multiple types of cancer
    Yuan, Jingsheng
    Tan, Lulu
    Yin, Zhijie
    Tao, Kaixiong
    Wang, Guobing
    Shi, Wenjia
    Gao, Jinbo
    ONCOLOGY LETTERS, 2019, 18 (03) : 2576 - 2583
  • [6] A high-throughput drug screen identifies auranofin as a potential sensitizer of cisplatin in small cell lung cancer
    Liu, Xiaoli
    Wang, Wei
    Yin, Yanping
    Li, Ming
    Li, Hong
    Xiang, Hang
    Xu, Ao
    Mei, Xiaodong
    Hong, Bo
    Lin, Wenchu
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (06) : 1166 - 1176
  • [7] A high-throughput drug screen identifies auranofin as a potential sensitizer of cisplatin in small cell lung cancer
    Xiaoli Liu
    Wei Wang
    Yanping Yin
    Ming Li
    Hong Li
    Hang Xiang
    Ao Xu
    Xiaodong Mei
    Bo Hong
    Wenchu Lin
    Investigational New Drugs, 2019, 37 : 1166 - 1176
  • [8] Identification of hub genes associated with EMT-induced chemoresistance in breast cancer using integrated bioinformatics analysis
    Kaur, Bhavjot
    Mukhlis, Yahya
    Natesh, Jagadish
    Penta, Dhanamjai
    Meeran, Syed Musthapa
    GENE, 2022, 809
  • [9] Integrative Analysis of the Doxorubicin-Associated LncRNA-mRNA Network Identifies Chemoresistance-Associated lnc-TRDMT1-5 as a Biomarker of Breast Cancer Progression
    Chen, Qi
    Yang, Hui
    Zhu, Xiaolan
    Xiong, Shangwan
    Chi, Huamao
    Xu, Wenlin
    FRONTIERS IN GENETICS, 2020, 11
  • [10] Genome-wide analysis of the FOXA1 transcriptional regulatory network identifies super enhancer associated LncRNAs in tamoxifen resistance
    Zhang, Xiulei
    Zhang, Qian
    Liu, Guangzhi
    FRONTIERS IN GENETICS, 2022, 13
1